Outset Medical (OM) Short term Debt (2019 - 2022)
Outset Medical (OM) posted quarterly Short term Debt of $1.0 million for Q2 2022, down 86.67% quarter-over-quarter from $7.5 million in Q4 2019.
Outset Medical (OM) Short term Debt (2019 - 2022) Analysis & Trends
Outset Medical (OM) has reported Short term Debt for 2 consecutive years, with $1.0 million the latest figure, recorded in Q2 2022.
- In Q2 2022, Short term Debt changed N/A year-over-year to $1.0 million; the TTM figure through Jun 2022 stood at $1.0 million (changed N/A YoY), while the FY2019 annual figure was $7.5 million, changed N/A from the prior year.
- Short term Debt retreated to $1.0 million in Q2 2022 per OM's latest filing, from $7.5 million in the prior quarter.
- Across five years, Short term Debt topped out at $7.5 million in Q4 2019 and bottomed at $1.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.00 Mn |
| Dec 31, 2019 | 7.50 Mn |